Advertisement
Advertisement

NVCT

NVCT logo

Nuvectis Pharma, Inc. Common Stock

19.41
USD
Sponsored
+0.54
+2.83%
Aug 11, 16:00 UTC -4
Closed
exchange

Pre-Market

19.38

-0.03
-0.15%

Nuvectis Pharma, Inc. Common Stock Profile

About

Nuvectis Pharma Inc. is a biopharmaceutical company. It focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. Nuvectis Pharma Inc. is based in Fort Lee, NJ.

Info & Links

CEO

Ron Bentsur

Headquarters

1 BRIDGE PLAZA, SUITE 275
FORT LEE, NJ 07024, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.nuvectis.com

Auditor

Kesselman & Kesselman

Share holders

7

Employees

13

Nuvectis Pharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

631.43M

Enterprise Value

609.27M

Enterprise Value/EBITDA(ttm)

-21.11

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

55.35

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-184.25%

Return on Invested Capital(ttm)

-190.64%

Return on Assets(ttm)

-105.24%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-28.87M

Net Income Available to Common(ttm)

-30.27M

Diluted EPS(ttm)

-1.31

Share Statistics

Beta (5Y Monthly)

-0.26

52-Week Change

216.64%

S&P 500 52-Week Change

19.90%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

32.58M

Dividend Yield

0.00%

Float4

23.28M

% Held by Insiders

28.55%

% Held by Institutions

96.77%

Balance Sheet

Total Cash(mrq)

22.16M

Total Cash Per Share(mrq)

0.68

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.68%

Quick Ratio(mrq)

1.68%

Book Value Per Share(mrq)

0.34

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.47

Free Cash Flow(ytd)

-11.04M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement